Robert James Wills

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Spring Lake, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Joseph Oliveto, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert James Wills

Form 4 holding Director

Alpha Cognition Inc.

Security class
Director Stock Option (Right to Buy)
Shares / value
30,019
Estimated value
Report date
07 Apr 2025
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Director

Oncternal Therapeutics, Inc.

Security class
Stock Options
Shares / value
2,200
Estimated value
Report date
20 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CymaBay Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
22 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Robert James Wills

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .